Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Conn. High Court Snapshot: Rehab Permit And Towing Tiff No Photo Available

Brian Steele

The Connecticut Supreme Court, in its upcoming term, will consider whether an existing substance abuse treatment center has the right ... (more story)

This Week's Healthcare Earnings: Moderna, CVS, Hims & Hers No Photo Available

Yeji Jesse Lee

Macro-headwinds continued to cloud over earnings calls this week as a smattering of companies, including Humana, Moderna and Teladoc, ... (more story)

New Suits Target HHS Cuts, PBM Rates And Med. Device Regs No Photo Available

Gianna Ferrarin

The Trump administration is facing a wave of new allegations over its restructuring of the Department of Health and Human Services, wi... (more story)